Latest Commercialisation News

Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.

Imagion Biosystems has reached key milestones in its MagSense® HER2 breast cancer imaging program, including starting manufacturing for its Phase 2 trial and launching an AI imaging protocol collaboration with Wayne State University.

Coda Minerals has announced a fully underwritten $8.33 million entitlement offer to fund the pre-feasibility study of its Elizabeth Creek Copper-Silver Project, offering shareholders a discounted entry price with attaching options.

D3 Energy has submitted its Production Right application for part of its South African ER315 permit well ahead of schedule and under budget, marking a key step toward commercialising certified methane and helium reserves.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

Carnegie Clean Energy has secured a pivotal role in a €4 million European Commission-funded project aimed at advancing wave energy technology and reducing costs. The initiative leverages Carnegie’s CETO platform to pioneer innovations that could reshape the future of ocean energy farms.

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.

ALCORE, ABx Group’s subsidiary, has secured government approval for overseas R&D activities and is pursuing a $5 million grant to accelerate its clean fluorine chemical technology commercialisation.

Kinetiko Energy has secured a crucial two-year renewal of its South African exploration rights, advancing its pilot production and development plans amid promising drilling results.

TMK Energy’s LF-07 pilot well at the Gurvantes XXXV Coal Seam Gas Project is producing over 100 cubic metres of gas daily, driving a doubling of total pilot well output since recent drilling. This milestone sets the stage for further production increases as reservoir management advances.

Green360 Technologies announces CEO Bojan Bogunovic's resignation effective October 31, with Executive Chairman Aaron Banks stepping in to lead daily operations during a pivotal growth phase.